Mustafa Çetiner

Prof. Mustafa Çetiner is a hematologist with a medical degree from Marmara University Faculty of Medicine (2000). He brings extensive clinical and academic experience, currently affiliated with Acibadem Health Group since 2019. His work focuses on hematology, stem cell and regenerative medicine, and related areas of internal medicine. He is active in national and international professional communities, holding memberships in the Turkish Medical Association, Turkish Hematology Association, Turkish Internal Medicine Specialty Society, Turkish Immunology Association, Turkish Society of Thrombosis and Hemostasis, and the University Faculty Members Association. Internationally, he is a member of the European Hematology Association, American Society of Hematology, European Bone Marrow Transplantation Registry, and the MDS Foundation. He also supports patient advocacy through the Cancer Fighters Association and contributes to developments in stem cell research via the Stem Cell and Regenerative Medicine Association. Colleagues and patients know him for combining evidence-based care with a patient-centered approach, and for his commitment to collaboration across clinical and research teams.

Education

• 2000 Marmara University Faculty of Medicine Hematology
• 1994 Karadeniz Technical University Faculty of Medicine Internal Medicine
• 1988 Ankara University Faculty of Medicine

Experience

• 2019 Acibadem Health Group
• 2016 – 2019 Head of Department of Internal Medicine, Koç University School of Medicine
• 2016 – 2019 Founder and Chairman of the Department of Internal Medicine, Koç University School of Medicine
• 2013 – 2019 Koç University School of Medicine Internal Medicine Coordinator
• 2008 – 2017 American Hospital Therapeutic Apheresis Responsible Physician
• 2013 Koç University School of Medicine / Professor
• 2010 – 2013 Şişli Memorial Hospital Bone Marrow Transplant Unit Director
• 2011 – 2012 Founder and Director of Şişli Memorial Hospital Bone Marrow Transplant Unit / Associate Professor
• 2010 WHO (World Health Organization) and UN (United Nations) Physician
• 2008 V.K.V. American Hospital Department of Hematology / Associate Professor
• 2006 – 2008 Marmara University / Internal Medicine / Hematology / Associate Professor
• 2001 – 2006 Marmara University / Internal Medicine / Hematology / Assistant Assoc.
• 2004 – 2005 Hematopetic Stem Cell Transplantation Program / Department of Medicine / Feinberg School of Medicine / Northwestern University / Guest Lecturer
• 1998 – 2001 Marmara University / Internal Medicine / Hematology / Specialist Dr.
• 1997 – 2000 Marmara University Faculty of Medicine / Internal Medicine / Hematology / Dr.Ar.Assist.
• 1994 – 1997 Ministry of National Education Beşevler Health Education Center / Specialist Dr.
• 1989 – 1994 Internal Medicine Faculty of Medicine Karadeniz Technical University / Dr.Ar.Assist.

Memberships

• Turkish Medical Association
• Cancer Fighters Association
• European Hematology Association
• American Society of Hematology
• European Bone Marrow Transplantation Registry
• Turkish Internal Medicine Specialty Society
• Turkish Hematology Association
• MDS Foundation
• Turkish Immunology Association
• University Faculty Members Association
• Stem Cell and Regenerative Medicine Association
• Turkish Society of Thrombosis and Hemostasis

Publications

• A multi-centric study on the efficacy of eltrombopag in management of refractory chronic immune thrombocytopenia
  Turk J Haematol. 2019 Jul 22. doi: 10.4274/tjh.galenos.2019.2018.0307. Cekdemir D, Guvenc S, Ozdemirkiran F, Eser A, Toptas T, Ozkocaman V, Haydaroglu Sahin H, Ermis Turak E, Esen R, Comert M, Sadri S, Aslaner M,
• The role of atopy in the pathogenesis of bleomycin pulmonary toxicity
  Respiratory Medicine. (2019) Ozyigit, L. P., Aktas, E. C., Senbas, Z. A., Ozturk, A. B., Ozturk, E., Ergonul, M. Tabak L, Ferhanoglu B, Cetiner M, Deniz G.
• Rituximab desensitization in three patients with severe rituximab allergy.
  Curr Probl Cancer. 2017 Sep- Oct;41(5): 349-354 Öztürk E, Özyiğit LP, Öztürk AB, Akay MO, Çetiner M, Ferhanoğlu B.
• Use of fluorodeoxyglucose positron emission tomography for diagnosis of bleomycin-induced pneumonitis in Hodgkin lymphoma
  Leuk Lymphoma. 2017 May;58(5):1114-1122 Falay O, Öztürk E, Bölükbaşı Y, Gümüş T, Örnek S, Özbalak M, Çetiner M, Demirkol O, Ferhanoğlu B.
• Implementation of an antimicrobial stewardship program for patients with febrile neutropenia
  Am J Infect Control. 2017 Nov 22. pii: S0196-6553(17) 31136-7. doi: 10.1016/j.ajic.2017.09.030. [Epub ahead of print] Madran B, Keske Ş, Tokça G, Dönmez E, Ferhanoğlu B, Çetiner M, Mandel NM, Ergönül Ö
• Iron deficiency and anemia in heart failure
  Turk Kardiyol Dern Ars. 2017 Mar;45(Suppl 2):1-38 Cavusoglu Y, Altay H, Cetiner M, Guvenc TS, Temizhan A, Ural D, Yesilbursa D, Yildirim N, Yilmaz MB.
• Diagnosis and treatment of iron deficiency anemia in patients with inflammatory bowel disease and gastrointestinal bleeding: iron deficiency anemia working group consensus report.
  Akpinar H, Cetiner M, Keshav S, Örmeci N, Törüner M.
• Complete Remission of Burkitt Lymphoma After Surgical Excision: A Case Report.
  Indian J Hematol Blood Transfus. 2016 Jun;32(Suppl 1):178-80 Bekoz HS, Kantarcioglu B, Tecimer T, Uskent N, Cetiner M, Ferhanoglu B, Sargin D.
• Comparison of International Prognostic Index and NCCN-IPI in 324 patients with de novo diffuse large B-cell lymphoma: a multi-center retrospective analysis.
  Leuk Lymphoma. 2016 May;57(5):1211-4. Öztürk E, Özbalak M, Berk S, Erdoğan I, Avşar E, Dolgun A, Çetiner M, Mandel NM, Yalnız FF, Elverdi T, Salihoğlu A, Eşkazan AE, Ar MC, Öngören Ş,
• Novel Masters of Erythropoiesis: Hypoxia Inducible Factors and Recent Advances in Anemia of Renal Disease.
  Blood Purif. 2016 Jun 18;42(2):160-167. Solak Y, Cetiner M, Siriopol D, Tarim K, Afsar B, Covic A, Kanbay M.
• GnRH agonist leuprolide acetate does not confer any protection against ovarian damage induced by chemotherapy and radiation in vitro
  Hum Reprod. 2015 Dec;30(12):2912-25. Bildik G, Akin N, Senbabaoglu F, Sahin GN, Karahuseyinoglu S, Ince U, Taskiran C, Selek U, Yakin K, Guzel Y, Ayhan C, Alper E, Cetiner M, Balaban B,
• Diagnostic contribution of (18) F-FDG-PET/CT in fever of unknown origin
  Int J Infect Dis. 2014; 19; 53-8 Tokmak H, Ergönul O, Demirkol O, Cetiner M, Ferhanoglu B
• Nonleukemic ureteral granulocytic sarcoma presenting with unilateral urinary obstruction and Hematuria
  Case Rep Urol. 2013 2013;2013:861232. doi: 10.1155/2013/861232. Epub 2013 Aug 19. Acar O, Esen T, Tecimer T, Cetiner M, Peker O, Musaoglu A
• Cyclosporin A therapy on idiopathic thrombotic thrombocytopenic purpura in relapse setting: two case reports and a review of literature
  Transfusion. 2013 53 (7): 1586-93 Yilmaz M, Eskazan AE, Unsal A, Taninmis H, Kara E, Cetiner M, Ferhanoglu B.
• Azacitidine has limited activity in “real life” patients with MDS and AML: a single centre experience
  Hematol Oncol 2011; 29: 1?6 Ozbalak M, Cetiner M, Bekoz H, Atesoglu EB, Ar C, Salihoglu A, Tuzuner N, Ferhanoglu B.
• Osteonecrosis of the jaw in patients with multiple myeloma treated with zoledronic acid
  J Bone Miner Metab. 2009;27(4):435-43 Cetiner S, Sucak GT, Kahraman SA, Akı SZ, Kocakahyaoglu B, Gultekin SE, Cetiner M, Haznedar R.
• Bortezomib: A New Therapeutic Option for POEMS Syndrome
  Eur J Haematol. 2009 Sep 3. 84(2):175-7 Kaygusuz I, Tezcan H, Cetiner M, Kocakaya O, Uzay A, Bayik M.
• L-Carnitine ameliorates methotrexate-induced oxidative organ injury and inhibits leukocyte death
  Cell Biol Toxicol 22 (1), 47-60, 2006 Şener, G., Eksioglu-Demiralp, E., Cetiner, M., Ercan, F., Şirvancı, S., Gedik, N., Yeğen, BC
• Beta-Glucan amoliorates methotrexate-induced oxidative organ injury via its antioxidant and immunomodulatory effects
  Eur J Pharmacol. 2006 Aug 7;542(1-3):170-8 Sener G, Eksioglu-Demiralp, E, Cetiner M, Ercan F, Yeggen BC.
• Tar.ine protects against methotrexate-induced toxicity and inhibits leucocyte death
  Toxicology and Applied Pharmacology 209 (1), 39-50 (2005) Cetiner, M., Şener, G., Şehirli, Ö., Eksioglu-Demiralp, E., Ercan, F., Şirvancı, S., Gedik, N., Akpolat, S., Tecimer, T., Yeğen, BC
• Non-B, non-T Neoplasms with Lymphoblast Morphology: Further Clarification and Classification
  Am J Surg Pathol, 28, 835-837 (2004). Ozdemirli, M., Cetiner, M
• Hairy Cell Leukemia in Father and Son
  Med Oncol, 20, 375-378 (2003). Cetiner, M., Adıgüzel, C., Argon, D., Ratip, S., Ekşioğlu-Demiralp, E., Tecimer, T., Bayık, M.
• Effect of Interferon-alpha-2a on Neutrophil Adhesion and Phagocytosis in Chronic Myeloid Leukemia and Behcet’s Disease
  Clin Rheumatol, 21, 211-214 (2002). Kart, S., Ovali, E., Ratip, S., Cetiner, M., Direskeneli, H., Bayık, M., Akoğlu, T
• COMPARISON OF TWO CRYOPRESERVATION METHODS ACCORDING TO STEM CELL VIABILITY AND COLONY FORMING CAPACITY
  International Journal of Hematology and Oncology, 28(4), 171-177. KARTI, S. S., ADIGÜZEL, C., YILMAZ, M., ÇETİNER, M., RATİP, S., EKŞİOĞLU, E., … & BAYIK, M.
• Clinical Microbiological Case: Chronic Disseminated Candidiasis
  Clinical Microbiology and Infection, 8, 435-436 (2002). Ratip, S., Odabaşı, Z., Kartı, S., Cetiner, M., Yeğen, C., Çerikçioğlu, N., Bayık, M., Korten, V
• Effectivness of FLAG chemotheraphy in refractory or relapsed acute myeloid leukemia
  Turk. J. Haematol, 18, 53-58.(2001) Ratip, S., Eryüksel, E., Odabaşı, Z., Çetiner, M., Özen, Y., Ovalı, E., … & Bayık, M.
• Normal Pressure Hydrocephalus Associated with Chronic Alpha Interferon Treatment: A Case Report
  Turk J Haematol, 17(1), 33-35.(2000) Ratip, S., Budak-Alpdoğan, T., Alpdoğan, Ö., Çetiner, M., Karti, S., ELMACI, İ., & Bayik, M.
• Effects of Omeprazole on Gallbladder Contraction in Humans
  Hepatogastroenterology, 47, 346-348 (2000). Kapıcıoğlu, S., Baki, A., Arslan, M., Cetiner, M., Cihanyurdu, N.
• Effects of angiotensin converting enzyme inhibitors in healthy rats and in rats with carbon tetrachloride-induced toxic hepatitis
  Turkish Journal of Medical Sciences, 30(4), 321-326.(2000) OVALI, E., ÇETİNER, M., RATİP, S., AYDIN, F., TEKELİOĞLU, Y., KARTI, S., … & AĞAOĞLU, N.
• Role of Hepatocyte Growth Factor in the Development of Dendritic Cells from CD 34+ Bone Marrow Cells
  Haematologica, 85, 464-469 (2000). Ovali, E., Ratip, S., Kibaroglu, A., Tekelioglu, Y., Cetiner, M., Karti, S., Aydin, F., Bayik, M., Akoglu, T.
• Measurement of unconjugated hyperbilirubinemia in Gilbert’s syndrome during compulsory fasting
  Marmara Medical Journal, 12(4), 171-174.(1999) Kapıcıoğlu, S., Çetiner, M., & Baki, A.
• Action of Buffered Aspirin (Alka-Seltzer)”on Gastric Mucosal Injury in Humans
  Annals of Medical Sciences, 8, 48-51.(1999) Kapicioglu, S., Cetiner, M., & Arslan, M.
• Bone marrow transplantation data for marmara university school of medicine: 1989-1998
  Marmara Medical Journal, 11(4), 204-209.(1998) Çetiner, M., Ratip, S., Ovalı, E., Kartı, S., Bayık, M., & Akoğlu, T.
• The effect of somatostatin analogue (SMS 201-995) on renal function in patients with decompensated cirrhosis and healthy volunteers
  Turk J Gastroeruerol, 7, 22-26.(1996) CETINER, M., OVALI, E., YIGITER, Y., & KAPICIOGLU, S.